Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019
ONSIW
ONSIW was delisted on the 3rd of December, 2018.
10 hedge funds and large institutions have $542K invested in Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 in 2017 Q2 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, 1 reducing their positions, and 0 closing their positions.
43% more funds holding
Funds holding: 7 → 10 (+3)
72% less capital invested
Capital invested by funds: $1.96M → $542K (-$1.41M)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VKH
Virtu KCG Holdings
New York
|
+$91.8K |
| 2 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
+$12.3K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$8.06K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$292K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SM
1
Sabby Management
Miami Beach,
Florida
| $277K | -$292K | -592,479 | -64% |
|
|
PA
2
Perceptive Advisors
New York
| $80K | – | – | – |
|
|
CAM
3
Cormorant Asset Management
Boston,
Massachusetts
| $72K | – | – | – |
|
|
ACA
4
Avoro Capital Advisors
New York
| $40K | – | – | – |
|
|
VKH
5
Virtu KCG Holdings
New York
| $32K | +$91.8K | +186,109 | New |
|
|
ACP
6
Acuta Capital Partners
Redwood City,
California
| $17K | – | – | – |
|
|
PC
7
PointState Capital
New York
| $17K | – | – | – |
|
|
MIM
8
Monashee Investment Management
Boston,
Massachusetts
| $4K | +$12.3K | +25,000 | New |
|
|
9
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $3K | +$8.06K | +16,332 | New |
|
ONSIW Hedge Fund Activity: Q2 2017 in Review
10 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 (ONSIW) for Q2 2017, worth a combined $542K — down 72% from $1.96M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new ONSIW positions and 0 closed out — a net gain of 3 holders — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Virtu KCG Holdings, opening a new position worth an estimated $91.8K. The largest seller was Sabby Management, cutting an estimated $292K.
- 10 institutional investors held Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 (ONSIW) as of Q2 2017, up from 7 in Q1 2017.
- Funds reported $542K of Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 stock for Q2 2017, down 72% quarter-over-quarter.
- 3 funds opened new Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 positions in Q2 2017 and 0 closed out, a net change of +3 holders.
- The largest Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 buyer in Q2 2017 was Virtu KCG Holdings, an estimated $91.8K added.
- The largest Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 seller in Q2 2017 was Sabby Management, an estimated $292K sold.
Based on aggregated 13F filings for Q2 2017.